HSV-2 Specifically Down Regulates HLA-C Expression to Render HSV-2-Infected DCs Susceptible to NK Cell Killing

PLoS Pathogens

Volumn 9, Issue 3, 2013, Pages

  Elboim, Moran ^a   Grodzovski, Inna ^a   Djian, Esther ^a   Wolf, Dana G ^a   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; GLUTAMIC ACID; GREEN FLUORESCENT PROTEIN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1;

ARTICLE; CELL KILLING; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DOWN REGULATION; GENE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; ICP47 GENE; NATURAL KILLER CELL; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

ADAPTIVE IMMUNITY; CELL SURVIVAL; CLONING, MOLECULAR; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 2, HUMAN; HLA-C ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION;

HARNESS; HUMAN HERPESVIRUS 2;

EID: 84875996982     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003226     Document Type: Article

References (45)

1. Hanna J, Mandelboim O, (2007) When killers become helpers. Trends Immunol 28: 201-206.
2. Wood SM, Ljunggren HG, Bryceson YT, (2011) Insights into NK cell biology from human genetics and disease associations. Cell Mol Life Sci 68: 3479-3493.
3. Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, et al. (2011) Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J Immunol 187: 3096-3103.
4. Gur C, Doron S, Kfir-Erenfeld S, Horwitz E, Abu-Tair L, et al. (2012) NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 61: 885-893.
5. Elboim M, Gazit R, Gur C, Ghadially H, Betser-Cohen G, et al. (2010) Tumor immunoediting by NKp46. J Immunol 184: 5637-5644.
6. Seidel E, Glasner A, Mandelboim O, (2012) Virus-mediated inhibition of natural cytotoxicity receptor recognition. Cell Mol Life Sci.
7. Raulet DH, Vance RE, (2006) Self-tolerance of natural killer cells. Nat Rev Immunol 6: 520-531.
8. Thielens A, Vivier E, Romagne F, (2012) NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr Opin Immunol 24: 239-245.
9. Pietra G, Romagnani C, Moretta L, Mingari MC, (2009) HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells. Curr Pharm Des 15: 3336-3344.
10. Mandelboim O, Reyburn HT, Vales-Gomez M, Pazmany L, Colonna M, et al. (1996) Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 184: 913-922.
11. Campbell KS, Purdy AK, (2011) Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 132: 315-325.
12. Weidanz JA, Hawkins O, Verma B, Hildebrand WH, (2011) TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. Int Rev Immunol 30: 328-340.
13. Lilley BN, Ploegh HL, (2005) Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev 207: 126-144.
14. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
15. Loenen WA, Bruggeman CA, Wiertz EJ, (2001) Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin Immunol 13: 41-49.
16. Dolan A, Jamieson FE, Cunningham C, Barnett BC, McGeoch DJ, (1998) The genome sequence of herpes simplex virus type 2. J Virol 72: 2010-2021.
17. Shukla SY, Singh YK, Shukla D, (2009) Role of nectin-1, HVEM, and PILR-alpha in HSV-2 entry into human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 50: 2878-2887.
18. Ashkar AA, Rosenthal KL, (2003) Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol 77: 10168-10171.
19. Milligan GN, Bernstein DI, (1997) Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229: 259-268.
20. Mohamed FA, Roberts M, Seton L, Ford JL, Levina M, et al. (2012) Production of extended release mini-tablets using directly compressible grades of HPMC. Drug Dev Ind Pharm [Epub ahead of print].
21. Tomazin R, van Schoot NE, Goldsmith K, Jugovic P, Sempe P, et al. (1998) Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol 72: 2560-2563.
22. Jugovic P, Hill AM, Tomazin R, Ploegh H, Johnson DC, (1998) Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol 72: 5076-5084.
23. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, et al. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
24. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O, (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376-385.
25. Berger JR, Houff S, (2008) Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 65: 596-600.
26. Boyington JC, Sun PD, (2002) A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol 38: 1007-1021.
27. Ishido S, Choi JK, Lee BS, Wang C, DeMaria M, et al. (2000) Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13: 365-374.
28. McSharry BP, Burgert HG, Owen DP, Stanton RJ, Prod'homme V, et al. (2008) Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. J Virol 82: 4585-4594.
29. Middeldorp JM, Pegtel DM, (2008) Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin Cancer Biol 18: 388-396.
30. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, et al. (2005) Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol 174: 2220-2227.
31. Blais ME, Dong T, Rowland-Jones S, (2011) HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology 133: 1-7.
32. Groth A, Kloss S, von Strandmann EP, Koehl U, Koch J, (2011) Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance. J Innate Immun 3: 344-354.
33. Odom CI, Gaston DC, Markert JM, Cassady KA, (2012) Human herpesviridae methods of natural killer cell evasion. Adv Virol 2012: 359869.
34. Thapa M, Kuziel WA, Carr DJ, (2007) Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 81: 3704-3713.
35. Kim M, Osborne NR, Zeng W, Donaghy H, McKinnon K, et al. (2012) Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. J Immunol 188: 4158-4170.
36. Galocha B, Hill A, Barnett BC, Dolan A, Raimondi A, et al. (1997) The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J Exp Med 185: 1565-1572.
37. Kulpa DA, Collins KL, (2011) The emerging role of HLA-C in HIV-1 infection. Immunology 134: 116-122.
38. Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, et al. (2011) An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9: 93-102.
39. Thomas M, Boname JM, Field S, Nejentsev S, Salio M, et al. (2008) Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci U S A 105: 1656-1661.
40. Spaggiari GM, Carosio R, Pende D, Marcenaro S, Rivera P, et al. (2001) NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 31: 1656-1665.
41. Han JY, Miller SA, Wolfe TM, Pourhassan H, Jerome KR, (2009) Cell type-specific induction and inhibition of apoptosis by Herpes Simplex virus type 2 ICP10. J Virol 83: 2765-2769.
42. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, et al. (2003) Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4: 609-615.
43. Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM, (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17: 314-317.
44. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
45. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, et al. (1999) Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci U S A 96: 5640-5644.